Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treatment of various diseases, including Parkinsons disease. Amicus Therapeutics reported the following financial data (in thousands) for three recent years:

	For Years Ended December 31
	Year 3		Year 2		Year 1
Cash and cash equivalents	$79,749		$49,060		$187,026
Net cash flows from operations	(299,955)		(213,695)		(150,147)

a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1 (in thousands). Round to one decimal place.

Year 3:	fill in the blank per month
Year 2:	fill in the blank per month
Year 1:	fill in the blank per month

b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place.

Year 3:	fill in the blank
Year 2:	fill in the blank
Year 1:	fill in the blank